Risk of Kava Hepatotoxicity and the FDA Consumer Advisory

被引:30
作者
Teschke, Rolf [1 ]
Schulze, Johannes [2 ]
机构
[1] Goethe Univ Frankfurt, Teaching Hosp, Dept Internal Med 2, Div Gastroenterol & Hepatol,Klinikum Hanau, D-63450 Hanau, Germany
[2] Goethe Univ Frankfurt, Fac Med, Off Dean, D-63450 Hanau, Germany
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2010年 / 304卷 / 19期
关键词
D O I
10.1001/jama.2010.1689
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
引用
收藏
页码:2174 / 2175
页数:2
相关论文
共 9 条
[1]
[Anonymous], 2007, ASS RISK HEP KAV PRO
[2]
*AUSTR GOV DEP HLT, 2005, KAV FACT SHEET
[3]
Quantification of kavalactones and determination of kava (Piper methysticum) chemotypes using near-infrared reflectance spectroscopy for quality control in Vanuatu [J].
Lasme, Privat ;
Davrieux, Fabrice ;
Montet, Didier ;
Lebot, Vincent .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2008, 56 (13) :4976-4981
[4]
The Kava Anxiety Depression Spectrum Study (KADSS): a randomized, placebo-controlled crossover trial using an aqueous extract of Piper methysticum [J].
Sarris, J. ;
Kavanagh, D. J. ;
Byrne, G. ;
Bone, K. M. ;
Adams, J. ;
Deed, G. .
PSYCHOPHARMACOLOGY, 2009, 205 (03) :399-407
[5]
Schmidt M., 2007, HERBALGRAM, V73, P45
[6]
Kava hepatotoxicity: pathogenetic aspects and prospective considerations [J].
Teschke, Rolf .
LIVER INTERNATIONAL, 2010, 30 (09) :1270-1279
[7]
Kava hepatotoxicity. A clinical review [J].
Teschke, Rolf .
ANNALS OF HEPATOLOGY, 2010, 9 (03) :251-265
[8]
U.S. Food and Drug Administration, CONS ADV KAV CONT DI
[9]
Flavokawain B, the hepatotoxic constituent from kava root, induces GSH-sensitive oxidative stress through modulation of IKK/NF-κB and MAPK signaling pathways [J].
Zhou, Ping ;
Gross, Shimon ;
Liu, Ji-Hua ;
Yu, Bo-Yang ;
Feng, Ling-Ling ;
Nolta, Jan ;
Sharma, Vijay ;
Piwnica-Worms, David ;
Qiu, Samuel X. .
FASEB JOURNAL, 2010, 24 (12) :4722-4732